TY  - RPRT
TI  - SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity
AU  - Neerukonda, S. N.
AU  - Vassell, R.
AU  - Lusvarghi, S.
AU  - Wang, R.
AU  - Echegaray, F.
AU  - Bentley, L.
AU  - Eakin, A. E.
AU  - Erlandson, K. J.
AU  - Katzelnick, L. C.
AU  - Weiss, C. D.
AU  - Wang, W.
PY  - 2021
DO  - 10.1101/2021.11.05.467523
UR  - https://www.biorxiv.org/content/10.1101/2021.11.05.467523v1
ID  - 10.1101/2021.11.05.467523
ER  -